OLMESARTAN MEDOXOMIL | A078276 | RISING PHARMA HOLDING INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Public Citizen FDA-2017-P-6513 · 14 docket documents Public Citizen, a consumer advocacy organization, filed this petition on November 15, 2017 under Section 355(e) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA immediately remove from the market all medications containing olmesartan medoxomil (marketed as Benicar, Benicar HCT, Az | Other | 2017-11-16 | Denied | Public Citizen |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.